Top Canadian Stocks to Buy Right Away With $5,000

Canadian investors looking to beat broader market returns should identify a portfolio of companies across sectors that are growing steadily. In this article, I have identified three top Canadian stocks to buy right now with $5,000.

Let’s see why.

Is this TSX stock still undervalued?

Valued at a market cap of $8.6 billion, B2Gold (TSX:BTO) is a Canada-based gold producer that has surged 87% over the last 12 months. B2Gold delivered strong third-quarter results with production exceeding expectations across its Fekola, Masbate, and Otjikoto mines.

However, operational challenges at its newly commissioned Goose mine forced the company to slash 2025 production guidance for that asset.

The miner reported adjusted earnings of US$0.14 per share and generated US$180 million in operating cash flow before working capital adjustments, benefiting from elevated gold prices.

Production outlook

The company achieved commercial production at Goose mine in October, just three months after the inaugural gold pour. But, crushing capacity shortfalls and delays accessing higher-grade ore from the Umwelt underground deposit forced it to revise production guidance down to between 50,000 and 80,000 ounces.

The gold miner implemented temporary mobile crushing units while permanent modifications to the primary crusher and secondary grinding circuits are being designed, with completion expected in 2026.

Underground mining at Umwelt commenced in late October and should ramp up quickly through year-end. Management maintained near-term production targets of approximately 250,000 ounces in 2026 and 330,000 ounces in 2027. It estimates an average annual output of 300,000 ounces over the initial six years.

B2Gold approved construction of the Antelope underground deposit in Namibia, with preproduction capital costs optimized down to US$105 million from the preliminary economic assessment estimate of US$129 million. Production from Antelope should boost Otjikoto output to approximately 110,000 ounces annually and extend mine life into the 2030s.

B2Gold ended the quarter with US$367 million in cash after drawing US$200 million on its revolving credit facility to manage working capital timing.

Analysts expect adjusted earnings per share to expand from US$0.52 in 2025 to US$1.02 in 2027. Even if the Canadian stock is priced eight times forward earnings, it could almost double over the next 12 months.

Is this TSX stock undervalued?

Valued at $146 million by market cap, Cardiol Therapeutics (TSX:CRDL) is a clinical-stage life sciences company. It focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Its lead product candidate is CardiolRx, which is in a Phase III multinational, randomized, double-blind, placebo-controlled study evaluating its efficacy and safety in acute myocarditis and for the treatment of recurrent pericarditis.

Cardiol is also developing CRD-38, an injection for subcutaneous administration, in preclinical development for the treatment of heart failure.

A pre-revenue company, Cardiol is forecast to grow revenue from $51.3 million in 2028 to $115.2 million in 2029. Analysts also expect the Canadian stock to turn free cash flow positive by 2028. Its FCF is forecast to improve from $9 million in 2028 to $51 million in 2029.

If Cardiol stock is priced at 10 times FCF, it could more than triple within the next four years.

The Foolish takeaway

Both B2Gold and Cardiol offer significant upside potential for shareholders in 2026. Moreover, B2Gold also offers additional diversification, given that gold has been viewed as a hedge against inflation and a store of value for several decades.

The post Top Canadian Stocks to Buy Right Away With $5,000 appeared first on The Motley Fool Canada.

Should you invest $1,000 in B2Gold Corp. right now?

Before you buy stock in B2Gold Corp., consider this:

The Motley Fool Canada team has identified what they believe are the top 10 TSX stocks for 2026… and B2Gold Corp. wasn’t one of them. The 10 stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 … if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,827.88!*

Now, it’s worth noting Stock Advisor Canada’s total average return is 102%* – a market-crushing outperformance compared to 81%* for the S&P/TSX Composite Index. Don’t miss out on our top 10 stocks, available when you join our mailing list!

Get the 10 stocks instantly #start_btn6 { background: #0e6d04 none repeat scroll 0 0; color: #fff; font-size: 1.2em; font-family: 'Montserrat', sans-serif; font-weight: 600; height: auto; line-height: 1.2em; margin: 30px 0; max-width: 350px; text-align: center; width: auto; box-shadow: 0 1px 0 rgba(0, 0, 0, 0.5), 0 1px 0 #fff inset, 0 0 2px rgba(0, 0, 0, 0.2); border-radius: 5px; } #start_btn6 a { color: #fff; display: block; padding: 20px; padding-right:1em; padding-left:1em; } #start_btn6 a:hover { background: #FFE300 none repeat scroll 0 0; color: #000; } @media (max-width: 480px) { div#start_btn6 { font-size:1.1em; max-width: 320px;} } margin_bottom_5 { margin-bottom:5px; } margin_top_10 { margin-top:10px; }

* Returns as of January 15th, 2026

More reading

• 1 Canadian Stock Ready to Start 2026 With a Bang
• How to Use Your TFSA to Double Your Annual Contribution
• 1 Incredible TSX Dividend Stock to Buy While it is Down 25%
• 2 Top Canadian Blue-Chip Stocks to Buy Now
• Is Brookfield Renewable Stock a Buy for its 5.4% Yield?

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends B2Gold. The Motley Fool has a disclosure policy.